United States Extracorporeal Co2 Removal Device Market Size & Outlook, 2026-2034
United States Extracorporeal Co2 Removal Device Market Insights
- As per Reed Intelligence insights, the United States Extracorporeal Co2 Removal Device Market stood at USD 34.9 Million in 2025 and is anticipated to grow to USD 109.26 Million by 2034.
- The United States market is expected to advance at a CAGR of 13.42% from 2026 through 2034.
- In 2025, Veno-Venous ECCO2R accounted for the highest share of the Type market size.
- During the forecast period, Veno-Venous ECCO2R is set to register the highest growth, making it the most lucrative Type segment.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, United States accounted for 24.07% of the global Extracorporeal Co2 Removal Device Market size.
- By 2034, United States is expected to lead the global Extracorporeal Co2 Removal Device Market in terms of market size.
- Within North America, United States is projected to dominate the regional Extracorporeal Co2 Removal Device Market size by 2034.
- United States is identified as the fastest-growing market in North America, anticipated to reach USD 108.43 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 34.9 Million |
| Market Size In 2034 | USD 109.26 Million |
| Largest segment | Veno-Venous ECCO2R |
| Units | Revenue in USD Million |
| CAGR | 13.42% (2026-2034) |
| Segmnetation Covered | |
| Type |
|
| Application |
|
| End-Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Extracorporeal Co2 Removal Device Market Type 2026-2034 (USD Million)
| Type | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Veno-Venous ECCO2R | XX.x | XX.x | XX.x | 17.51 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Arterio-Venous ECCO2R | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Portable ECCO2R Systems | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United States Extracorporeal Co2 Removal Device Market Application 2026-2034 (USD Million)
| Application | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Critical Care | XX.x | XX.x | XX.x | 17.05 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Emergency Care | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Chronic Respiratory Management | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
United States Extracorporeal Co2 Removal Device Market End-Use 2026-2034 (USD Million)
| End-Use | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | XX.x | XX.x | XX.x | 18.18 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Ambulatory Surgical Centers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Specialty Clinics | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
